PROGRESS REPORT

                 A WARM DAY, ON SANTORINI

Here is a summary of recent research directions specific to ovarian cancer.  As we all know by now, immunotherapy has been disappointing in the treatment of OVCA, although to this the author is cautiously (and vaguely) optimistic.  Several treatments that help prolong life are mentioned – including PARPi, with which you are already familiar.  Acronyms you might not recognize are TP53 inhibitors, and Wee 1 inhibitors.  Both interfere with cell division and thus “inhibit” the proliferation of fast-dividing cancer cells.  Alas, not cures, but helpful all the same.

This is an oral presentation, which I was unable to play owing to the fact that my computer was designed sometime in the 19^th century.  Fortunately, a printed summary also is required.  I wonder what I missed.

https://www.targetedonc.com/view/future-directions-in-ovarian-cancer